Future research should focus on elucidating the dynamic changes of Musclin across different stages of hypertension, its concentration-dependent effects, and its interactions with vascular remodeling and the inflammatory microenvironment, in order to clarify its potential value as a therapeutic target. The gene discussed is OSTN; the disease is Hypertension.